Yext, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Yext, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jan 31, 2018 | $48.02M | Mar 16, 2018 |
| FY2018 | Oct 31, 2017 | $44.33M | Mar 16, 2018 |
| FY2018 | Jul 31, 2017 | $40.77M | Mar 16, 2018 |
| FY2018 | Apr 30, 2017 | $37.08M | Mar 16, 2018 |
| FY2018 | Jan 31, 2017 | $35.67M | Mar 16, 2018 |
| FY2018 | Oct 31, 2016 | $31.91M | Mar 16, 2018 |
| FY2018 | Jul 31, 2016 | $29.56M | Mar 16, 2018 |
| FY2018 | Apr 30, 2016 | $27.13M | Mar 16, 2018 |
| FY2018 | Jan 31, 2016 | $89.72M | Mar 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $446.58M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $420.96M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $404.32M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $400.85M | Mar 13, 2025 |
| FY2022 | Jan 31, 2022 | $100.93M | Mar 18, 2022 |
| FY2022 | Oct 31, 2021 | $99.53M | Mar 18, 2022 |
| FY2022 | Jul 31, 2021 | $98.12M | Mar 18, 2022 |
| FY2022 | Apr 30, 2021 | $91.99M | Mar 18, 2022 |
| FY2022 | Jan 31, 2021 | $92.19M | Mar 18, 2022 |
| FY2022 | Oct 31, 2020 | $89.06M | Mar 18, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $332.51M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $324.59M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $316.85M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $296.89M | Mar 13, 2025 |
| FY2022 | Jan 31, 2022 | $76.36M | Mar 18, 2022 |
| FY2022 | Oct 31, 2021 | $74.27M | Mar 18, 2022 |
| FY2022 | Jul 31, 2021 | $71.51M | Mar 18, 2022 |
| FY2022 | Apr 30, 2021 | $70.14M | Mar 18, 2022 |
| FY2022 | Jan 31, 2021 | $70.60M | Mar 18, 2022 |
| FY2022 | Oct 31, 2020 | $67.42M | Mar 18, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $37.87M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | ($27.95M) | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | ($2.63M) | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | ($65.94M) | Mar 13, 2025 |
| FY2022 | Jan 31, 2022 | ($23.11M) | Mar 18, 2022 |
| FY2022 | Oct 31, 2021 | ($24.93M) | Mar 18, 2022 |
| FY2022 | Jul 31, 2021 | ($27.59M) | Mar 18, 2022 |
| FY2022 | Apr 30, 2021 | ($17.63M) | Mar 18, 2022 |
| FY2022 | Jan 31, 2021 | ($18.31M) | Mar 18, 2022 |
| FY2022 | Oct 31, 2020 | ($22.04M) | Mar 18, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $44.55M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | ($32.45M) | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | ($6.20M) | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | ($64.83M) | Mar 13, 2025 |
| FY2022 | Jan 31, 2022 | ($21.96M) | Mar 18, 2022 |
| FY2022 | Oct 31, 2021 | ($24.35M) | Mar 18, 2022 |
| FY2022 | Jul 31, 2021 | ($26.41M) | Mar 18, 2022 |
| FY2022 | Apr 30, 2021 | ($17.23M) | Mar 18, 2022 |
| FY2022 | Jan 31, 2021 | ($19.14M) | Mar 18, 2022 |
| FY2022 | Oct 31, 2020 | ($21.76M) | Mar 18, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $89.87M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $77.20M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $72.04M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $70.90M | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | $68.35M | Mar 13, 2024 |
| FY2023 | Jan 31, 2021 | $58.15M | Mar 17, 2023 |
| FY2022 | Jan 31, 2020 | $49.45M | Mar 18, 2022 |
| FY2021 | Jan 31, 2019 | $36.10M | Mar 16, 2021 |
| FY2020 | Jan 31, 2018 | $25.69M | Mar 20, 2020 |
| FY2019 | Jan 31, 2017 | $19.32M | Mar 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $55.85M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $50.21M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $46.16M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $17.85M | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | $21.85M | Mar 13, 2024 |
| FY2023 | Jan 31, 2021 | $1.20M | Mar 17, 2023 |
| FY2022 | Jan 31, 2020 | ($30.77M) | Mar 18, 2022 |
| FY2021 | Jan 31, 2019 | $5.24M | Mar 16, 2021 |
| FY2020 | Jan 31, 2018 | ($32.41M) | Mar 20, 2020 |
| FY2019 | Jan 31, 2017 | ($13.53M) | Mar 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.56M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $2.09M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $2.73M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $6.19M | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | $13.42M | Mar 13, 2024 |
| FY2023 | Jan 31, 2021 | $65.11M | Mar 17, 2023 |
| FY2022 | Jan 31, 2020 | $11.89M | Mar 18, 2022 |
| FY2021 | Jan 31, 2019 | $5.27M | Mar 16, 2021 |
| FY2020 | Jan 31, 2018 | $3.67M | Mar 20, 2020 |
| FY2019 | Jan 31, 2017 | $3.51M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $621.78M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $610.08M | Mar 10, 2026 |
| FY2025 | Jan 31, 2024 | $508.81M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $523.76M | Mar 13, 2024 |
| FY2023 | Jan 31, 2022 | $620.34M | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | $595.99M | Mar 18, 2022 |
| FY2021 | Jan 31, 2020 | $563.62M | Mar 16, 2021 |
| FY2020 | Jan 31, 2019 | $267.13M | Mar 20, 2020 |
| FY2019 | Jan 31, 2018 | $203.49M | Mar 15, 2019 |
| FY2018 | Jan 31, 2017 | $86.47M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $462.36M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $456.89M | Mar 10, 2026 |
| FY2025 | Jan 31, 2024 | $361.64M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $395.74M | Mar 13, 2024 |
| FY2023 | Jan 31, 2022 | $408.47M | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | $388.75M | Mar 18, 2022 |
| FY2021 | Jan 31, 2020 | $362.41M | Mar 16, 2021 |
| FY2020 | Jan 31, 2019 | $182.58M | Mar 20, 2020 |
| FY2019 | Jan 31, 2018 | $122.04M | Mar 15, 2019 |
| FY2018 | Jan 31, 2017 | $93.61M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $159.42M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $153.19M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $147.17M | Mar 10, 2026 |
| FY2026 | Jan 31, 2023 | $128.02M | Mar 10, 2026 |
| FY2025 | Jan 31, 2022 | $211.87M | Mar 13, 2025 |
| FY2024 | Jan 31, 2021 | $207.24M | Mar 13, 2024 |
| FY2023 | Jan 31, 2020 | $201.21M | Mar 17, 2023 |
| FY2022 | Jan 31, 2019 | $84.55M | Mar 18, 2022 |
| FY2021 | Jan 31, 2018 | $81.45M | Mar 16, 2021 |
| FY2020 | Jan 31, 2017 | ($127.76M) | Mar 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $110.80M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $96.78M | Mar 10, 2026 |
| FY2025 | Jan 31, 2024 | $4.48M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $4.48M | Mar 13, 2024 |
| FY2023 | Jan 31, 2022 | $4.57M | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | $4.84M | Mar 18, 2022 |
| FY2021 | Jan 31, 2020 | $4.53M | Mar 16, 2021 |
| FY2020 | Jan 31, 2019 | $4.66M | Mar 20, 2020 |
| FY2019 | Jan 31, 2018 | $4.92M | Mar 15, 2019 |
| FY2019 | Jan 31, 2017 | $4.44M | Mar 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($669.25M) | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | ($707.12M) | Mar 10, 2026 |
| FY2025 | Jan 31, 2024 | ($679.17M) | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | ($676.54M) | Mar 13, 2024 |
| FY2023 | Jan 31, 2022 | ($610.60M) | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | ($517.35M) | Mar 18, 2022 |
| FY2021 | Jan 31, 2020 | ($422.65M) | Mar 16, 2021 |
| FY2020 | Jan 31, 2019 | ($301.11M) | Mar 20, 2020 |
| FY2019 | Jan 31, 2018 | ($233.45M) | Mar 15, 2019 |
| FY2018 | Jan 31, 2017 | ($166.89M) | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $154.12M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $123.13M | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | $210.18M | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | $190.21M | Mar 13, 2025 |
| FY2023 | Jan 31, 2022 | $261.21M | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | $230.41M | Mar 18, 2022 |
| FY2022 | Jan 31, 2020 | $256.08M | Mar 18, 2022 |
| FY2021 | Jan 31, 2019 | $91.76M | Mar 16, 2021 |
| FY2020 | Jan 31, 2018 | $34.37M | Mar 20, 2020 |
| FY2019 | Jan 31, 2017 | $24.42M | Mar 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $97.96M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | $0 | Mar 10, 2026 |
| FY2018 | Jan 31, 2018 | $0 | Mar 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | 0 | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | 0 | Mar 13, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | 0 | Mar 10, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | 0 | Mar 13, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 17, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 122.93M | Mar 10, 2026 |
| FY2026 | Jan 31, 2025 | 127.00M | Mar 10, 2026 |
| FY2025 | Jan 31, 2024 | 124.87M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | 122.33M | Mar 13, 2024 |
| FY2023 | Jan 31, 2022 | 131.16M | Mar 17, 2023 |
| FY2022 | Jan 31, 2021 | 123.99M | Mar 18, 2022 |
| FY2021 | Jan 31, 2020 | 115.83M | Mar 16, 2021 |
| FY2020 | Jan 31, 2019 | 102.17M | Mar 20, 2020 |
| FY2019 | Jan 31, 2018 | 93.98M | Mar 15, 2019 |
| FY2018 | Jan 31, 2017 | 31.39M | Mar 16, 2018 |